News

Specialist bioactive growth factor protein manufacturer Qkine today announced a new partnership with StemCultures, a life sciences company dedicated to developing innovative reagents that enhance the quality and efficiency of cell growth and differentiation in culture.

The manufacture of cell and gene therapy products and tissue-engineered regenerative medicine products often requires recombinant proteins such as growth factors and cytokines. These are classified as raw or ancillary materials ie. culture media components or reagents that are not intended to be included in the final product.

We've recently fully transitioned to an animal origin-free (AOF) manufacturing process for our recombinant proteins. This shift ensures the highest standards of safety, purity, and sustainability in bioproduction. By eliminating all animal-derived components, including heparin-based purification columns, we’re supporting ethical and cruelty-free biomanufacturing. Learn more about our journey to 100% AOF.

As part of our commitment to constantly improving growth factor quality and availability, we will introduce a modest price increase on January 1st 2024.

Qkine has appointed Thomas Scientific as a new US Distribution Partner, making it easier for stem cell scientists in the US to purchase the entire Qkine product portfolio.

Qkine is pleased to announce a new sales distribution agreement with industry-leading European distributor, CliniSciences.

Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus

Qkine is excited to be shortlisted for the Business Weekly Awards 2023 alongside scaling and inspirational companies in the Cambridge cluster.

Qkine partners with the UK’s new £12M cellular agriculture manufacturing hub, CARMA, to revolutionize sustainable food production

Qkine is delighted to extended its global reach by agreeing a new sales distribution agreement with Biogenuix, an Indian distribution partner.

Qkine is delighted to announce its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.

On Friday, 28th April 2023, Qkine officially opened its new HQ at Murdoch House, Cambridge, UK. We were delighted to be joined by Mayor Dr. Nik Johnson, the Mayor of Cambridge & Peterborough, alongside our team, customers, investors, and representatives from the Cambridge ecosystem.